Home
News
Create
Screeners
Insights
Norris Medicines
13.
33
-0.17
(-1.26%)
Market Cap
₹13.33 Cr
PE Ratio
-24.11
Industry
Commercial Services
Buy
Sell
Company Performance:
1D
-1.26%
1M
-9.69%
6M
-19.50%
1Y
-35.23%
5Y
+122.17%
View Company Insights
Latest news about Norris Medicines
Norris Medicines Limited Announces Q3 FY26 Financial Results
6 days ago
Norris Medicines Limited's Board of Directors approved unaudited financial results for the quarter and year ended December 31, 2025, during a meeting held on February 14, 2026. The 30-minute board meeting was conducted in compliance with SEBI regulations, and the company plans to publish these results in newspapers as per regulatory requirements.
Norris Medicines Independent Director Ms. Sathya Venkatachalam Resigns Due to Personal Reasons
Dec 12, 2025
Norris Medicines Successfully Completes NAFDAC Regulatory Audit in Nigeria
Dec 12, 2025
Bombay High Court Allows Norris Medicines' Criminal Appeal, Sets Aside ₹1.33 Crore Deposit Order
Dec 11, 2025
Norris Medicines Reports Q2 FY26 Loss of Rs 102.86 Lakhs Amid Operational Challenges
Nov 15, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation